logo

For the Inventor, By the Inventor

Waltham, MA, United States of America

Folkert Reck

This inventor holds 5 USPTO granted patents and 4 published patent applications. Top assignee: Astrazeneca Ab. Active years: 2007-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Folkert Reck. Retrieved from https://idiyas.com/inventor/folkert-reck-4cl1enw9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 48(Granted Patents)


Company Filing History:

goldMedal5 out of 1,534 
 
Astrazeneca Ab
 patents

Years Active: 2007-2012

Loading Chart...
5 patents (USPTO):Explore Patents
1. 8124602 - Compounds for the treatment of multi-drug resistant bacterial infections (2012-02-28),
2. 7875715 - Compounds for the treatment of multi-drug resistant bacterial infections (2011-01-25),
3. 7498350 - Oxazolidinones as antibacterial agents (2009-03-03),
4. 7473699 - 3-cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and their use as antibacterial agents (2009-01-06),
5. 7199143 - Chemical compounds (2007-04-03),

Title: Folkert Reck: Innovator in Antibacterial Compounds

Introduction

Folkert Reck is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of antibacterial treatments, holding a total of 5 patents. His work focuses on developing compounds that address multi-drug resistant bacterial infections, which is a growing concern in modern medicine.

Latest Patents

Reck's latest patents include innovative compounds for the treatment of multi-drug resistant bacterial infections. These compounds demonstrate antibacterial activity and involve processes for their preparation. They are formulated into pharmaceutical compositions that serve as active ingredients in medicaments. The inventions specifically target the treatment of bacterial infections in warm-blooded animals, including humans. The compounds are designed to be used in the manufacture of medicaments aimed at combating these infections effectively.

Career Highlights

Folkert Reck is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to the development of critical medical solutions that address pressing health issues. Reck's expertise in the field of antibacterial compounds has positioned him as a key player in the fight against antibiotic resistance.

Collaborations

Throughout his career, Reck has collaborated with esteemed colleagues, including Michael Barry Gravestock and Neil James Hales. These collaborations have fostered an environment of innovation and have led to advancements in the development of effective antibacterial treatments.

Conclusion

Folkert Reck's contributions to the field of antibacterial compounds are invaluable in the ongoing battle against multi-drug resistant infections. His innovative work at AstraZeneca and his collaborations with other experts highlight his commitment to improving health outcomes. Reck's inventions are paving the way for new treatments that can save lives and enhance the quality of care for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…